Skip to main content
. 2017 Oct 23;9:116. doi: 10.1186/s13148-017-0412-9

Table 1.

Clinical factors and HOXD10 methylation in 117 cases of HCC samples

Clinical factor No. HOXD10 methylation status *P value
Unmethylated n = 27 (23.1%) Methylated n = 90 (76.9%)
Age (year) 0.799
 < 60 80 19 61
 ≥ 60 37 8 29
Gender 0.248
 Male 101 21 80
 Female 16 6 10
HBV infection 0.762
 Yes 85 19 66
 No 32 8 24
Liver cirrhosis 0.093
 Yes 88 17 71
 No 29 10 19
Tumor size (cm) 0.231
 ≤ 5 37 6 31
 > 5 80 21 59
Number of lesions 0.681
 1 92 22 70
 ≥ 1 25 5 20
Differentiation 0.044*
 Well 8 4 4
 Moderate 74 19 55
 Poor 35 4 31
TNM stage 0.377
 Stage I + stage II 52 14 38
 Stage III + stage IV 65 13 52
Lymph node metastasis 0.867
 Negative 112 26 86
 Positive 5 1 4
Vessel cancerous embolus 0.049*
 Negative 87 24 63
 Positive 30 3 27

*P values are obtained from chi-square test, significant difference, *P < 0.05